{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:17:15Z","timestamp":1792588635352,"version":"4.5.0"},"reference-count":213,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004880","name":"Xinjiang Medical University","doi-asserted-by":"publisher","award":["XYD2024GR05"],"award-info":[{"award-number":["XYD2024GR05"]}],"id":[{"id":"10.13039\/501100004880","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017438","name":"Xinjiang Uyghur Autonomous Region People's Government","doi-asserted-by":"publisher","award":["2024B03037-3"],"award-info":[{"award-number":["2024B03037-3"]}],"id":[{"id":"10.13039\/100017438","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bbcan.2026.189640","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T23:22:49Z","timestamp":1781911369000},"page":"189640","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Programming regulated cell death to engineer whole-tumor-cell vaccines for cancer immunotherapy"],"prefix":"10.1016","volume":"1881","author":[{"given":"Yingchao","family":"Guan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Die","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasen","family":"Maimaitiyiming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbcan.2026.189640_bb0005","first-page":"571","article-title":"Bispecific chimeric T cell receptors tackle tumor heterogeneity. Nat","volume":"6","year":"2025","journal-title":"Cancer"},{"key":"10.1016\/j.bbcan.2026.189640_bb0010","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.3747\/co.27.5223","article-title":"A review of cancer immunotherapy: from the past, to the present, to the future","volume":"27","author":"Esfahani","year":"2020","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.bbcan.2026.189640_bb0015","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejca.2017.08.032","article-title":"Patient-reported outcomes in KEYNOTE-006, a randomised study of pembrolizumab versus ipilimumab in patients with advanced melanoma","volume":"86","author":"Petrella","year":"2017","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bbcan.2026.189640_bb0020","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41571-023-00754-1","article-title":"Long-term outcomes following CAR T cell therapy: what we know so far","volume":"20","author":"Cappell","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2026.189640_bb0025","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.3390\/curroncol29050247","article-title":"Immune checkpoint inhibitors in cancer therapy","volume":"29","author":"Shiravand","year":"2022","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.bbcan.2026.189640_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2025.155864","article-title":"Exploring immune checkpoint inhibitors: focus on PD-1\/PD-L1 axis and beyond","volume":"269","author":"Aden","year":"2025","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.bbcan.2026.189640_bb0035","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1126\/science.1840703","article-title":"A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma","volume":"254","author":"van der Bruggen","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2026.189640_bb0040","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1126\/science.aaa6204","article-title":"T cell exclusion, immune privilege, and the tumor microenvironment","volume":"348","author":"Joyce","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2026.189640_bb0045","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adr1299","article-title":"Intratumoral antigen-presenting cell activation by a nanovesicle for the concurrent tertiary lymphoid structure de novo neogenesis","volume":"11","author":"Cheng","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bbcan.2026.189640_bb0050","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1016\/j.immuni.2025.09.003","article-title":"Intra-tumoral hypoxia promotes CD8(+) T cell dysfunction via chronic activation of integrated stress response transcription factor ATF4","volume":"58","author":"Alicea Pauneto","year":"2025","journal-title":"Immunity"},{"key":"10.1016\/j.bbcan.2026.189640_bb0055","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41422-019-0164-5","article-title":"The molecular machinery of regulated cell death","volume":"29","author":"Tang","year":"2019","journal-title":"Cell Res."},{"key":"10.1016\/j.bbcan.2026.189640_bb0060","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/s41392-022-01110-y","article-title":"Regulated cell death (RCD) in cancer: key pathways and targeted therapies","volume":"7","author":"Peng","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbcan.2026.189640_bb0065","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1390263","article-title":"Emerging role of immunogenic cell death in cancer immunotherapy","volume":"15","author":"Arimoto","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189640_bb0070","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","article-title":"Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018","volume":"25","author":"Galluzzi","year":"2018","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbcan.2026.189640_bb0075","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1007\/s00018-016-2209-y","article-title":"Regulated cell death and adaptive stress responses","volume":"73","author":"Galluzzi","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbcan.2026.189640_bb0080","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1016\/j.molcel.2025.06.005","article-title":"MLKL activates the cGAS-STING pathway by releasing mitochondrial DNA upon necroptosis induction","volume":"85","author":"Ding","year":"2025","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbcan.2026.189640_bb0085","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/nri.2017.21","article-title":"Mitochondrial DNA in innate immune responses and inflammatory pathology","volume":"17","author":"West","year":"2017","journal-title":"Nat. Rev. Immunol."},{"issue":"Suppl. 7","key":"10.1016\/j.bbcan.2026.189640_bb0090","doi-asserted-by":"crossref","first-page":"vii15","DOI":"10.1093\/neuonc\/nov159","article-title":"Vaccination strategies for neuro-oncology","volume":"17","author":"Sampson","year":"2015","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.bbcan.2026.189640_bb0095","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1080\/10428194.2024.2381651","article-title":"A phase I trial of vaccination with lethally irradiated lymphoma cells admixed with granulocyte-macrophage colony-stimulating factor secreting K562 cells for the treatment of follicular lymphoma","volume":"65","author":"Jacobsen","year":"2024","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.bbcan.2026.189640_bb0100","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s40164-025-00703-x","volume":"14","author":"Fernandez","year":"2025","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.bbcan.2026.189640_bb0105","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1515\/jtim-2025-0004","article-title":"Targeting regulated cell death: apoptosis, necroptosis, pyroptosis, ferroptosis, and cuproptosis in anticancer immunity","volume":"13","author":"Guo","year":"2025","journal-title":"J. Transl. Int. Med."},{"key":"10.1016\/j.bbcan.2026.189640_bb0110","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.cell.2023.11.044","article-title":"Cell death","volume":"187","author":"Newton","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2026.189640_bb0115","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s41419-024-06712-8","article-title":"Research progress on morphology and mechanism of programmed cell death","volume":"15","author":"Chen","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbcan.2026.189640_bb0120","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13054-025-05278-x","article-title":"The role of programmed cell death in organ dysfunction induced by opportunistic pathogens","volume":"29","author":"Wang","year":"2025","journal-title":"Crit. Care"},{"key":"10.1016\/j.bbcan.2026.189640_bb0125","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41420-022-00982-x","article-title":"Targeting lncRNAs in programmed cell death as a therapeutic strategy for non-small cell lung cancer","volume":"8","author":"Luo","year":"2022","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.bbcan.2026.189640_bb0130","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3389\/fimmu.2015.00501","article-title":"Modulation of APC function and anti-tumor immunity by anti-cancer drugs","volume":"6","author":"Martin","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189640_bb0135","article-title":"Programmed cell death tunes tumor immunity","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189640_bb0140","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/s41416-023-02327-6","article-title":"Whole tumour cell-based vaccines: tuning the instruments to orchestrate an optimal antitumour immune response","volume":"129","author":"Perez-Banos","year":"2023","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbcan.2026.189640_bb0145","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1416115","article-title":"Exploiting cell death and tumor immunity in cancer therapy: challenges and future directions","volume":"12","author":"Lu","year":"2024","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bbcan.2026.189640_bb0150","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1089\/ars.2024.0558","article-title":"DAMPening tumor immune escape: the role of endoplasmic reticulum chaperones in immunogenic chemotherapy","volume":"41","author":"Cifric","year":"2024","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bbcan.2026.189640_bb0155","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2022.2096363","article-title":"Trial watch: dendritic cell (DC)-based immunotherapy for cancer","volume":"11","author":"Laureano","year":"2022","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.bbcan.2026.189640_bb0160","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/imr.13301","article-title":"Decoding immunogenic cell death from a dendritic cell perspective","volume":"321","author":"Janssens","year":"2024","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.bbcan.2026.189640_bb0165","doi-asserted-by":"crossref","first-page":"6020","DOI":"10.1038\/s41467-025-60769-3","article-title":"Orchestrating intratumoral DC-T cell immunity for enhanced tumor control via radiotherapy-activated TLR7\/8 prodrugs in mice","volume":"16","author":"Yin","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189640_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2025.102677","article-title":"Lenalidomide-utilizing self-assembled immunogenic cell death-inducing heparin\/doxorubicin nanocomplex for anticancer immunotherapy","volume":"62","author":"Seo","year":"2025","journal-title":"Nano Today"},{"key":"10.1016\/j.bbcan.2026.189640_bb0175","doi-asserted-by":"crossref","first-page":"36323","DOI":"10.1021\/acsnano.5c09413","article-title":"Spatiotemporally controlled nanomicelles for synergistic phototherapy and immune reprogramming in triple-negative breast cancer","volume":"19","author":"Chang","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.bbcan.2026.189640_bb0180","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1056\/NEJMoa061760","article-title":"Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases","volume":"356","author":"Garland","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbcan.2026.189640_bb0185","first-page":"131","article-title":"Vaccines for immunoprevention of cancer","author":"Enokida","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2026.189640_bb0190","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1126\/science.aar7112","article-title":"Personalized vaccines for cancer immunotherapy","volume":"359","author":"Sahin","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2026.189640_bb0195","article-title":"Cancer vaccine from intracellularly gelated tumor cells functionalized with CD47 blockage and damage-associated molecular pattern exposure","volume":"6","author":"Gao","year":"2025","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.bbcan.2026.189640_bb0200","article-title":"Neoadjuvant chemotherapy by liposomal doxorubicin boosts immune protection of tumor membrane antigens-based nanovaccine","volume":"6","author":"Chen","year":"2025","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.bbcan.2026.189640_bb0205","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature23003","article-title":"Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer","volume":"547","author":"Sahin","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189640_bb0210","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/s41423-018-0184-y","article-title":"TLR9 agonist enhances radiofrequency ablation-induced CTL responses, leading to the potent inhibition of primary tumor growth and lung metastasis","volume":"16","author":"Xu","year":"2019","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.bbcan.2026.189640_bb0215","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13045-024-01634-6","article-title":"Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition","volume":"18","author":"Glaviano","year":"2025","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bbcan.2026.189640_bb0220","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1007\/s12094-020-02344-4","article-title":"Cellular immunotherapy: a clinical state-of-the-art of a new paradigm for cancer treatment","volume":"22","author":"Rodriguez Perez","year":"2020","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.bbcan.2026.189640_bb0225","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/cr.2016.157","article-title":"Dendritic cell-based immunotherapy","volume":"27","author":"Sabado","year":"2017","journal-title":"Cell Res."},{"key":"10.1016\/j.bbcan.2026.189640_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.celbio.2025.100180","article-title":"A precision-engineered dendritic cell-targeted mRNA nanovaccine for enhanced antiviral immunity","author":"Qin","year":"2025","journal-title":"Cell Biomater."},{"key":"10.1016\/j.bbcan.2026.189640_bb0235","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41551-025-01343-6","article-title":"Targeting vaccines to dendritic cells by mimicking the processing and presentation of antigens in xenotransplant rejection","volume":"9","author":"Wang","year":"2025","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.bbcan.2026.189640_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2025.101135","article-title":"Identification of 68 HLA-A24 and -A2-restricted cytotoxic T lymphocyte-inducing peptides derived from 10 common cancer-specific antigens frequently expressed in various solid cancers","volume":"61","author":"Kinoshita","year":"2025","journal-title":"Neoplasia"},{"key":"10.1016\/j.bbcan.2026.189640_bb0245","article-title":"Ddx21 mutant peptide is an effective neoantigen in prophylactic lung cancer vaccines and activates long-term anti-tumor immunity","volume":"16","author":"Zhang","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189640_bb0250","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1001\/jamaoncol.2018.4051","article-title":"Combining immune checkpoint blockade and tumor-specific vaccine for patients with incurable human papillomavirus 16-related cancer: a phase 2 clinical trial","volume":"5","author":"Massarelli","year":"2019","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.bbcan.2026.189640_bb0255","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.4161\/hv.28077","article-title":"Safety and efficacy of DNA vaccines: plasmids vs. minicircles","volume":"10","author":"Stenler","year":"2014","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.bbcan.2026.189640_bb0260","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12985-025-02645-6","article-title":"Revolutionizing immunization: a comprehensive review of mRNA vaccine technology and applications","volume":"22","author":"Leong","year":"2025","journal-title":"Virol. J."},{"key":"10.1016\/j.bbcan.2026.189640_bb0265","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/s41541-024-01017-5","article-title":"A randomized trial comparing safety, immunogenicity and efficacy of self-amplifying mRNA and adenovirus-vector COVID-19 vaccines","volume":"9","author":"Ho","year":"2024","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.bbcan.2026.189640_bb0270","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/s41586-024-08033-4","article-title":"Probiotic neoantigen delivery vectors for precision cancer immunotherapy","volume":"635","author":"Redenti","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189640_bb0275","first-page":"14","article-title":"Therapeutic vaccination for glioblastoma elicited by retargeted oncolytic herpes virus","author":"Piaggio","year":"2026","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bbcan.2026.189640_bb0280","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41541-018-0095-z","article-title":"From therapeutic antibodies to immune complex vaccines","volume":"4","author":"Wang","year":"2019","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.bbcan.2026.189640_bb0285","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s10238-024-01436-7","article-title":"Personalized neoantigen cancer vaccines: current progression, challenges and a bright future","volume":"24","author":"Wu","year":"2024","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.bbcan.2026.189640_bb0290","doi-asserted-by":"crossref","first-page":"5121","DOI":"10.1016\/j.cell.2025.08.025","article-title":"Multi-adjuvant personalized neoantigen vaccines: fine-tuning anti-cancer T cells","volume":"188","author":"Wang","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2026.189640_bb0295","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41423-024-01245-8","article-title":"Immunogenicity of cell death and cancer immunotherapy with immune checkpoint inhibitors","volume":"22","author":"Catanzaro","year":"2025","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.bbcan.2026.189640_bb0300","doi-asserted-by":"crossref","first-page":"4550","DOI":"10.1158\/1078-0432.CCR-11-0116","article-title":"Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy","volume":"17","author":"Rosenberg","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189640_bb0305","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1073\/pnas.90.8.3539","article-title":"Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity","volume":"90","author":"Dranoff","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbcan.2026.189640_bb0310","doi-asserted-by":"crossref","DOI":"10.1002\/imed.1025","article-title":"Whole tumor cell vaccines engineered to secrete GM-CSF (GVAX)","volume":"1","author":"Soiffer","year":"2021","journal-title":"ImmunoMedicine"},{"key":"10.1016\/j.bbcan.2026.189640_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122703","article-title":"Hydrogel activation of mincle receptors for tumor cell processing: a novel approach in cancer immunotherapy","volume":"311","author":"Lin","year":"2024","journal-title":"Biomaterials"},{"key":"10.1016\/j.bbcan.2026.189640_bb0320","first-page":"12","article-title":"Engineered GM-CSF polarizes protumorigenic tumor-associated macrophages to an antitumorigenic phenotype and potently synergizes with IL-12 immunotherapy","author":"Kang","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bbcan.2026.189640_bb0325","first-page":"911","article-title":"Cancer vaccines: the next immunotherapy frontier","volume":"3","author":"Lin","year":"2022","journal-title":"Nat. Can."},{"key":"10.1016\/j.bbcan.2026.189640_bb0330","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41568-021-00346-0","article-title":"Therapeutic cancer vaccines","volume":"21","author":"Saxena","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2026.189640_bb0335","doi-asserted-by":"crossref","DOI":"10.4028\/b-wjQRP6","article-title":"rWTC-MBTA vaccine induces potent adaptive immune responses against glioblastomas via dynamic activation of dendritic cells","volume":"11","author":"Wang","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.bbcan.2026.189640_bb0340","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41541-019-0103-y","article-title":"Turning the corner on therapeutic cancer vaccines","volume":"4","author":"Hollingsworth","year":"2019","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.bbcan.2026.189640_bb0345","first-page":"6","article-title":"Cryo-shocked cancer cells for targeted drug delivery and vaccination","author":"Ci","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bbcan.2026.189640_bb0350","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jare.2022.03.002","article-title":"The inactivation and destruction of viruses by reactive oxygen species generated through physical and cold atmospheric plasma techniques: current status and perspectives","volume":"43","author":"Kaushik","year":"2023","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.bbcan.2026.189640_bb0355","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41541-024-00995-w","article-title":"A highly immunogenic UVC inactivated Sabin based polio vaccine","volume":"9","author":"Tobin","year":"2024","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.bbcan.2026.189640_bb0360","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.23411","article-title":"Heat inactivation of serum interferes with the immunoanalysis of antibodies to SARS-CoV-2","volume":"34","author":"Hu","year":"2020","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.bbcan.2026.189640_bb0365","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/s41420-023-01671-z","article-title":"Establishing safe high hydrostatic pressure devitalization thresholds for autologous head and neck cancer vaccination and reconstruction","volume":"9","author":"Maletzki","year":"2023","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.bbcan.2026.189640_bb0370","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/ijc.28766","article-title":"High hydrostatic pressure induces immunogenic cell death in human tumor cells","volume":"135","author":"Fucikova","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2026.189640_bb0375","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1007\/s00262-006-0127-9","article-title":"Hypochlorous acid enhances immunogenicity and uptake of allogeneic ovarian tumor cells by dendritic cells to cross-prime tumor-specific T cells","volume":"55","author":"Chiang","year":"2006","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.bbcan.2026.189640_bb0380","first-page":"56","article-title":"Immunogenicity characterization of COVID-19 vaccines: a systematic review and meta-analysis","author":"Vasconcelos","year":"2023","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/j.bbcan.2026.189640_bb0385","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1093\/jjco\/hyaf078","article-title":"A randomized, placebo-controlled phase III trial of an autologous, formalin-fixed tumor vaccine for newly diagnosed glioblastoma: trial protocol","volume":"55","author":"Muragaki","year":"2025","journal-title":"Jpn. J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2026.189640_bb0390","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1016\/j.vaccine.2018.05.093","article-title":"Examination of the effects of virus inactivation methods on the induction of antibody- and cell-mediated immune responses against whole inactivated H9N2 avian influenza virus vaccines in chickens","volume":"36","author":"Astill","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.bbcan.2026.189640_bb0395","first-page":"11","article-title":"Developing effective cancer vaccines using rendered-inactive tumor cells","author":"Zhao","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.bbcan.2026.189640_bb0400","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202408685","article-title":"Photocatalytic carbon dots-triggered pyroptosis for whole cancer cell vaccines","volume":"36","author":"Cheng","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bbcan.2026.189640_bb0405","doi-asserted-by":"crossref","DOI":"10.4161\/21624011.2014.968434","article-title":"Physical modalities inducing immunogenic tumor cell death for cancer immunotherapy","volume":"3","author":"Adkins","year":"2014","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.bbcan.2026.189640_bb0410","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1357217","article-title":"Personalized cancer vaccine design using AI-powered technologies","volume":"15","author":"Kumar","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189640_bb0415","article-title":"A new personalized vaccine strategy based on inducing the pyroptosis of tumor cells in vivo by transgenic expression of a truncated GSDMD N-terminus","volume":"13","author":"He","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189640_bb0420","first-page":"13","article-title":"Apoptosis, a metabolic \u201chead-to-head\u201d between tumor and T cells: implications for immunotherapy","author":"Franzese","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.bbcan.2026.189640_bb0425","doi-asserted-by":"crossref","first-page":"3874","DOI":"10.1016\/j.molcel.2025.09.007","article-title":"DAMPs in the immunogenicity of cell death","volume":"85","author":"Chen","year":"2025","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbcan.2026.189640_bb0430","article-title":"A systematic review of apoptosis in correlation with cancer: should apoptosis be the ultimate target for cancer treatment?","volume":"14","author":"Abaza","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.bbcan.2026.189640_bb0435","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41420-025-02415-x","article-title":"Ferroptosis: CD8(+)T cells\u2019 blade to destroy tumor cells or poison for self-destruction","volume":"11","author":"Liang","year":"2025","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.bbcan.2026.189640_bb0440","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/35037710","article-title":"The biochemistry of apoptosis","volume":"407","author":"Hengartner","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189640_bb0445","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1126\/science.281.5381.1305","article-title":"Death receptors: signaling and modulation","volume":"281","author":"Ashkenazi","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2026.189640_bb0450","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrm3722","article-title":"Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy","volume":"15","author":"Czabotar","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbcan.2026.189640_bb0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2025.189280","article-title":"MOMP: a critical event in cell death regulation and anticancer treatment","volume":"1880","author":"Liu","year":"2025","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.bbcan.2026.189640_bb0460","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nri2545","article-title":"Immunogenic and tolerogenic cell death","volume":"9","author":"Green","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbcan.2026.189640_bb0465","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41420-025-02376-1","article-title":"Cell death in tumor microenvironment: an insight for exploiting novel therapeutic approaches","volume":"11","author":"Wang","year":"2025","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.bbcan.2026.189640_bb0470","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/s41423-023-01018-9","article-title":"The critical role of apoptosis in mesenchymal stromal cell therapeutics and implications in homeostasis and normal tissue repair","volume":"20","author":"Giacomini","year":"2023","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.bbcan.2026.189640_bb0475","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S1074-7613(00)80400-8","article-title":"Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-3ba;B pathway","volume":"7","author":"Chaudhary","year":"1997","journal-title":"Immunity"},{"key":"10.1016\/j.bbcan.2026.189640_bb0480","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.celrep.2019.12.079","article-title":"Quantitative and dynamic catalogs of proteins released during apoptotic and necroptotic cell death","volume":"30","author":"Tanzer","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbcan.2026.189640_bb0485","doi-asserted-by":"crossref","first-page":"E11721","DOI":"10.1073\/pnas.1811432115","article-title":"Molecular mechanisms of biogenesis of apoptotic exosome-like vesicles and their roles as damage-associated molecular patterns","volume":"115","author":"Park","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbcan.2026.189640_bb0490","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/cmi.2009.59","article-title":"Mitoxantrone-mediated apoptotic B16-F1 cells induce specific anti-tumor immune response","volume":"6","author":"Cao","year":"2009","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.bbcan.2026.189640_bb0495","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1038\/s41423-024-01217-y","article-title":"MLKL-mediated endothelial necroptosis drives vascular damage and mortality in systemic inflammatory response syndrome","volume":"21","author":"Wu","year":"2024","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.bbcan.2026.189640_bb0500","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.biomaterials.2018.02.033","article-title":"Necroptotic cancer cells-mimicry nanovaccine boosts anti-tumor immunity with tailored immune-stimulatory modality","volume":"164","author":"Kang","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.bbcan.2026.189640_bb0505","doi-asserted-by":"crossref","first-page":"6043","DOI":"10.1038\/s41467-024-50450-6","article-title":"Necroptosis enhances \u2018don\u2019t eat me\u2019 signal and induces macrophage extracellular traps to promote pancreatic cancer liver metastasis","volume":"15","author":"Liao","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189640_bb0510","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.immuni.2015.11.024","article-title":"Immunogenic chemotherapy sensitizes tumors to checkpoint blockade therapy","volume":"44","author":"Pfirschke","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.bbcan.2026.189640_bb0515","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2507028122","article-title":"Intercellular propagation of RIPK1\/RIPK3 amyloid fibrils","volume":"122","author":"Ma","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbcan.2026.189640_bb0520","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nature10558","article-title":"Non-canonical inflammasome activation targets caspase-11","volume":"479","author":"Kayagaki","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189640_bb0525","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nri.2016.58","article-title":"Inflammasomes: mechanism of assembly, regulation and signalling","volume":"16","author":"Broz","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbcan.2026.189640_bb0530","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41580-025-00837-0","article-title":"Mechanistic insights into gasdermin-mediated pyroptosis","volume":"26","author":"Bai","year":"2025","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbcan.2026.189640_bb0535","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41586-020-2071-9","article-title":"Gasdermin E suppresses tumour growth by activating anti-tumour immunity","volume":"579","author":"Zhang","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189640_bb0540","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202408415","article-title":"Injectable autocatalytic hydrogel triggers pyroptosis to stimulate anticancer immune response for preventing postoperative tumor recurrence","volume":"12","author":"Rao","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.bbcan.2026.189640_bb0545","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1021\/acsbiomaterials.4c00108","article-title":"Nanoparticle-mediated immunotherapy in triple-negative breast cancer","volume":"10","author":"Wang","year":"2024","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.bbcan.2026.189640_bb0550","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41392-024-01769-5","article-title":"Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies","volume":"9","author":"Zhou","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbcan.2026.189640_bb0555","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1126\/science.abf0529","article-title":"Copper induces cell death by targeting lipoylated TCA cycle proteins","volume":"375","author":"Tsvetkov","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2026.189640_bb0560","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/s41392-022-01229-y","article-title":"Copper homeostasis and cuproptosis in health and disease","volume":"7","author":"Chen","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbcan.2026.189640_bb0565","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41556-023-01091-2","article-title":"Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis","volume":"25","author":"Liu","year":"2023","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbcan.2026.189640_bb0570","article-title":"Integrated multiomic analysis reveals disulfidptosis subtypes in glioblastoma: implications for immunotherapy, targeted therapy, and chemotherapy","volume":"15","author":"Yang","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189640_bb0575","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1038\/s41594-025-01546-0","article-title":"Recruitment of Atg1 to the phagophore by Atg8 orchestrates autophagy machineries","volume":"32","author":"Song","year":"2025","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.bbcan.2026.189640_bb0580","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1080\/15548627.2020.1739447","article-title":"Mitochondrial DNA stress triggers autophagy-dependent ferroptotic death","volume":"17","author":"Li","year":"2021","journal-title":"Autophagy"},{"key":"10.1016\/j.bbcan.2026.189640_bb0585","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev-immunol-032712-100008","article-title":"Immunogenic cell death in cancer therapy","volume":"31","author":"Kroemer","year":"2013","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.bbcan.2026.189640_bb0590","doi-asserted-by":"crossref","first-page":"5803","DOI":"10.2147\/CMAR.S257966","article-title":"Metformin induces autophagy via the AMPK-mTOR signaling pathway in human hepatocellular carcinoma cells","volume":"12","author":"Gao","year":"2020","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.bbcan.2026.189640_bb0595","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1158\/2159-8290.CD-17-0996","article-title":"Targeting the lysosome for cancer therapy","volume":"7","author":"Towers","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbcan.2026.189640_bb0600","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109848","article-title":"Lysosomal Zn(2+) release triggers rapid, mitochondria-mediated, non-apoptotic cell death in metastatic melanoma","volume":"37","author":"Du","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbcan.2026.189640_bb0605","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202412730","article-title":"Lysosome targeted nanoparticle aggregation reverses immunosuppressive tumor microenvironment for cancer immunotherapy","volume":"36","author":"Xing","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bbcan.2026.189640_bb0610","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116174","article-title":"Parthanatos: mechanisms, modulation, and therapeutic prospects in neurodegenerative disease and stroke","volume":"228","author":"Yang","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbcan.2026.189640_bb0615","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.2741\/3297","article-title":"Parthanatos, a messenger of death","volume":"14","author":"David","year":"2009","journal-title":"Front. Biosci. (Landmark Ed)"},{"key":"10.1016\/j.bbcan.2026.189640_bb0620","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41568-023-00574-6","article-title":"Endocytosis in cancer and cancer therapy","volume":"23","author":"Banushi","year":"2023","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"10.1016\/j.bbcan.2026.189640_bb0625","article-title":"Anoikis in cell fate, physiopathology, and therapeutic interventions","volume":"2024","author":"Mei","year":"2020","journal-title":"MedComm"},{"key":"10.1016\/j.bbcan.2026.189640_bb0630","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s12032-025-02612-9","article-title":"Roles of anoikis in hepatocellular carcinoma: mechanisms and therapeutic potential","volume":"42","author":"Chen","year":"2025","journal-title":"Med. Oncol."},{"issue":"149\u2013168","key":"10.1016\/j.bbcan.2026.189640_bb0635","article-title":"Synergism of TNF-alpha and IFN-gamma triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes","volume":"184","author":"Karki","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2026.189640_bb0640","doi-asserted-by":"crossref","first-page":"7155","DOI":"10.1016\/j.cell.2025.11.002","article-title":"Innate immune and metabolic signals induce mitochondria-dependent membrane lysis via mitoxyperiosis","volume":"188","author":"Wang","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2026.189640_bb0645","doi-asserted-by":"crossref","first-page":"4854","DOI":"10.1111\/jcmm.14356","article-title":"Immunogenic cell death in cancer therapy: present and emerging inducers","volume":"23","author":"Zhou","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.bbcan.2026.189640_bb0650","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/nm1622","article-title":"Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy","volume":"13","author":"Apetoh","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbcan.2026.189640_bb0655","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/s41577-024-01027-3","article-title":"DAMP sensing and sterile inflammation: intracellular, intercellular and inter-organ pathways","volume":"24","author":"Huang","year":"2024","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbcan.2026.189640_bb0660","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.immuni.2024.03.002","article-title":"DAMPs and DAMP-sensing receptors in inflammation and diseases","volume":"57","author":"Ma","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.bbcan.2026.189640_bb0665","doi-asserted-by":"crossref","first-page":"E5910","DOI":"10.1073\/pnas.1705242114","article-title":"Sec61 blockade by mycolactone inhibits antigen cross-presentation independently of endosome-to-cytosol export","volume":"114","author":"Grotzke","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbcan.2026.189640_bb0670","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2023.102356","article-title":"Major histocompatibility complex class I assembly within endolysosomal pathways","volume":"84","author":"Olson","year":"2023","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.bbcan.2026.189640_bb0675","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/s41423-021-00753-1","article-title":"Metabolic programming in dendritic cells tailors immune responses and homeostasis","volume":"19","author":"Moller","year":"2022","journal-title":"Cell. Mol. Immunol."},{"issue":"711\u2013723","key":"10.1016\/j.bbcan.2026.189640_bb0680","article-title":"Tumor-residing Batf3 dendritic cells are required for effector T cell trafficking and adoptive T cell therapy","volume":"31","author":"Spranger","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2026.189640_bb0685","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2023.101992","article-title":"Gene-activating nanomedicine for the tumor-oriented infiltration of T cells to enhance immunotherapy against solid tumors","volume":"52","author":"Zhang","year":"2023","journal-title":"Nano Today"},{"key":"10.1016\/j.bbcan.2026.189640_bb0690","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13046-023-02918-4","article-title":"NK cell-triggered CCL5\/IFN\u03b3-CXCL9\/10 axis underlies the clinical efficacy of neoadjuvant anti-HER2 antibodies in breast cancer","volume":"43","author":"Santana-Hern\u00e1ndez","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189640_bb0695","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.immuni.2016.07.008","article-title":"Bioenergetic insufficiencies due to metabolic alterations regulated by the inhibitory receptor PD-1 are an early driver of CD8(+) T cell exhaustion","volume":"45","author":"Bengsch","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.bbcan.2026.189640_bb0700","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1038\/s41467-025-57603-1","article-title":"Interleukin-16 enhances anti-tumor immune responses by establishing a Th1 cell-macrophage crosstalk through reprogramming glutamine metabolism in mice","volume":"16","author":"Wen","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189640_bb0705","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nri.2016.107","article-title":"Immunogenic cell death in cancer and infectious disease","volume":"17","author":"Galluzzi","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbcan.2026.189640_bb0710","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1038\/s41467-023-39607-x","article-title":"Ultrasound-responsive low-dose doxorubicin liposomes trigger mitochondrial DNA release and activate cGAS-STING-mediated antitumour immunity","volume":"14","author":"Wang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189640_bb0715","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.immuni.2024.03.014","article-title":"Control of adaptive immunity by pattern recognition receptors","volume":"57","author":"Carroll","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.bbcan.2026.189640_bb0720","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41568-024-00690-x","article-title":"Cancer therapy with antibodies","volume":"24","author":"Paul","year":"2024","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2026.189640_bb0725","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.actbio.2022.09.014","article-title":"Exosome transportation-mediated immunosuppression relief through cascade amplification for enhanced apoptotic body vaccination","volume":"153","author":"Zhao","year":"2022","journal-title":"Acta Biomater."},{"key":"10.1016\/j.bbcan.2026.189640_bb0730","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/s41392-022-01182-w","article-title":"A small molecule inhibitor of the UBE2F-CRL5 axis induces apoptosis and radiosensitization in lung cancer","volume":"7","author":"Xu","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbcan.2026.189640_bb0735","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/s41419-024-06801-8","article-title":"Necroptosis stimulates interferon-mediated protective anti-tumor immunity","volume":"15","author":"Rucker","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbcan.2026.189640_bb0740","doi-asserted-by":"crossref","first-page":"4505","DOI":"10.1038\/s41467-023-40207-y","article-title":"Generation of whole tumor cell vaccine for on-demand manipulation of immune responses against cancer under near-infrared laser irradiation","volume":"14","author":"Meng","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189640_bb0745","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/s41586-025-08758-w","article-title":"STING agonist-based ER-targeting molecules boost antigen cross-presentation","volume":"641","author":"Wang","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189640_bb0750","first-page":"8","article-title":"Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity","author":"Efimova","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bbcan.2026.189640_bb0755","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202304407","article-title":"Supramolecularly engineered conjugate of bacteria and cell membrane-coated magnetic nanoparticles for enhanced ferroptosis and immunotherapy of tumors","volume":"10","author":"Xie","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.bbcan.2026.189640_bb0760","doi-asserted-by":"crossref","DOI":"10.1038\/s41418-026-01728-3","article-title":"Extracellular GPX4 functions as an immunosuppressive DAMP in ferroptosis","author":"Meng","year":"2026","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbcan.2026.189640_bb0765","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1038\/s41467-022-31218-2","article-title":"Cancer cells dying from ferroptosis impede dendritic cell-mediated anti-tumor immunity","volume":"13","author":"Wiernicki","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189640_bb0770","article-title":"Biomimic nanodrugs overcome tumor immunosuppressive microenvironment to enhance cuproptosis\/chemodynamic-induced cancer immunotherapy","volume":"12","author":"Wu","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.bbcan.2026.189640_bb0775","first-page":"11","article-title":"Conductive coordination nanozyme prodrugs precisely trigger pyroptosis, cuproptosis and ferroptosis for in situ cancer vaccination","author":"Wang","year":"2026","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbcan.2026.189640_bb0780","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1186\/s12951-025-03616-3","article-title":"Nanoparticles induced cuproptosis to enhance antitumor immunotherapy","volume":"23","author":"Deng","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.bbcan.2026.189640_bb0785","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/s41556-020-0496-x","article-title":"Cystine transporter regulation of pentose phosphate pathway dependency and disulfide stress exposes a targetable metabolic vulnerability in cancer","volume":"22","author":"Liu","year":"2020","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbcan.2026.189640_bb0790","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/cdd.2013.75","article-title":"Molecular mechanisms of ATP secretion during immunogenic cell death","volume":"21","author":"Martins","year":"2014","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbcan.2026.189640_bb0795","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41423-022-00956-0","article-title":"Arsenic trioxide elicits prophylactic and therapeutic immune responses against solid tumors by inducing necroptosis and ferroptosis","volume":"20","author":"Chen","year":"2023","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.bbcan.2026.189640_bb0800","first-page":"133","article-title":"Lysosomal lipid peroxidation regulates tumor immunity","author":"Bhardwaj","year":"2023","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2026.189640_bb0805","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216435","article-title":"LW-213 induces immunogenic tumor cell death via ER stress mediated by lysosomal TRPML1","volume":"577","author":"Zhu","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbcan.2026.189640_bb0810","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202404693","article-title":"Methuosis inducer SGI-1027 cooperates with everolimus to promote apoptosis and pyroptosis by triggering lysosomal membrane permeability in renal cancer","volume":"11","author":"Luo","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.bbcan.2026.189640_bb0815","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.chembiol.2015.03.007","article-title":"Extracellular poly(ADP-ribose) is a pro-inflammatory signal for macrophages","volume":"22","author":"Krukenberg","year":"2015","journal-title":"Chem. Biol."},{"key":"10.1016\/j.bbcan.2026.189640_bb0820","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1016\/j.vaccine.2005.01.015","article-title":"Immunotherapy with autologous tumor cell-BCG vaccine in patients with colon cancer: a prospective study of medical and economic benefits","volume":"23","author":"Uyl-de Groot","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.bbcan.2026.189640_bb0825","first-page":"217","article-title":"Autologous tumor cell vaccine induces antitumor T cell immune responses in patients with mantle cell lymphoma: a phase I\/II trial","author":"Frank","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbcan.2026.189640_bb0830","doi-asserted-by":"crossref","first-page":"955","DOI":"10.3389\/fimmu.2018.00955","article-title":"Changes in the TCRbeta repertoire and tumor immune signature from a cutaneous melanoma patient immunized with the CSF-470 vaccine: a case report","volume":"9","author":"Aris","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189640_bb0835","article-title":"VACCIMEL, an allogeneic melanoma vaccine, efficiently triggers T cell immune responses against neoantigens and alloantigens, as well as against tumor-associated antigens","volume":"15","author":"Carri","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189640_bb0840","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1634\/theoncologist.2011-0234","article-title":"Phase II trial of neoadjuvant docetaxel and CG1940\/CG8711 followed by radical prostatectomy in patients with high-risk clinically localized prostate cancer","volume":"18","author":"Vuky","year":"2013","journal-title":"Oncologist"},{"key":"10.1016\/j.bbcan.2026.189640_bb0845","doi-asserted-by":"crossref","unstructured":"Michael BD, Syndikus I, Clark A, Baborie A. Diffuse primary leptomeningeal melanocytosis in a patient receiving a novel cancer cell vaccine for prostate cancer. BMJ Case Rep. 2010; 2010. Doi: https:\/\/doi.org\/10.1136\/bcr.11.2009.2495.","DOI":"10.1136\/bcr.11.2009.2495"},{"key":"10.1016\/j.bbcan.2026.189640_bb0850","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1016\/j.ejca.2015.07.035","article-title":"A phase III study of belagenpumatucel-L, an allogeneic tumour cell vaccine, as maintenance therapy for non-small cell lung cancer","volume":"51","author":"Giaccone","year":"2015","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bbcan.2026.189640_bb0855","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s11605-012-2064-6","article-title":"Addition of algenpantucel-L immunotherapy to standard adjuvant therapy for pancreatic cancer: a phase 2 study","volume":"17","author":"Hardacre","year":"2013","journal-title":"J. Gastrointest. Surg."},{"key":"10.1016\/j.bbcan.2026.189640_bb0860","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/SLA.0000000000004669","article-title":"A phase 3 randomized clinical trial of chemotherapy with or without algenpantucel-L (HyperAcute-pancreas) immunotherapy in subjects with borderline resectable or locally advanced unresectable pancreatic cancer","volume":"275","author":"Hewitt","year":"2022","journal-title":"Ann. Surg."},{"key":"10.1016\/j.bbcan.2026.189640_bb0865","year":"2012"},{"key":"10.1016\/j.bbcan.2026.189640_bb0870","first-page":"13","article-title":"Tumor heterogeneity: a great barrier in the age of cancer immunotherapy","author":"El-Sayes","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbcan.2026.189640_bb0875","first-page":"12","article-title":"Cancer vaccine therapeutics: limitations and effectiveness-A literature review","author":"Kaczmarek","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.bbcan.2026.189640_bb0880","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/s41571-020-0341-y","article-title":"Targeting apoptosis in cancer therapy","volume":"17","author":"Carneiro","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2026.189640_bb0885","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/cr.2015.56","article-title":"Methylation-dependent loss of RIP3 expression in cancer represses programmed necrosis in response to chemotherapeutics","volume":"25","author":"Koo","year":"2015","journal-title":"Cell Res."},{"key":"10.1016\/j.bbcan.2026.189640_bb0890","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41577-020-00490-y","article-title":"Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity","volume":"21","author":"Veglia","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbcan.2026.189640_bb0895","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbcan.2026.189640_bb0900","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.70493","article-title":"Reprogrammed MDSCs promote Th1-dominant antitumour response via CD40 induced by autocrine TNF-\u03b1 after combining cryo-thermal therapy with IL6 and IL17A neutralization","volume":"15","author":"Hao","year":"2025","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.bbcan.2026.189640_bb0905","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/s41422-025-01145-0","article-title":"Human myelocyte and metamyelocyte-stage neutrophils suppress tumor immunity and promote cancer progression","volume":"35","author":"Liu","year":"2025","journal-title":"Cell Res."},{"key":"10.1016\/j.bbcan.2026.189640_bb0910","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1084\/jem.20050915","article-title":"Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death","volume":"202","author":"Casares","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbcan.2026.189640_bb0915","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.immuni.2020.01.014","article-title":"Blockade of the phagocytic receptor MerTK on tumor-associated macrophages enhances P2X7R-dependent STING activation by tumor-derived cGAMP","volume":"52","author":"Zhou","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.bbcan.2026.189640_bb0920","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1038\/s41423-020-00630-3","article-title":"Necroptosis, pyroptosis and apoptosis: an intricate game of cell death","volume":"18","author":"Bertheloot","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.bbcan.2026.189640_bb0925","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s10565-025-10025-7","article-title":"Lipotoxicity, lipid peroxidation and ferroptosis: a dilemma in cancer therapy","volume":"41","author":"Ma","year":"2025","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.bbcan.2026.189640_bb0930","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/s12672-025-02335-3","article-title":"Research progress on cuproptosis and copper related anti-tumor therapy","volume":"16","author":"Li","year":"2025","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.bbcan.2026.189640_bb0935","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jare.2023.09.018","article-title":"Nanomedicine-induced programmed cell death enhances tumor immunotherapy","volume":"62","author":"Lu","year":"2024","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.bbcan.2026.189640_bb0940","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41377-024-01673-1","article-title":"A self-assembling nanoplatform for pyroptosis and ferroptosis enhanced cancer photoimmunotherapy","volume":"14","author":"Wang","year":"2025","journal-title":"Light Sci. Appl."},{"key":"10.1016\/j.bbcan.2026.189640_bb0945","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/s41418-020-00658-y","article-title":"The intrinsic immunogenic properties of cancer cell lines, immunogenic cell death, and how these influence host antitumor immune responses","volume":"28","author":"Aaes","year":"2021","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbcan.2026.189640_bb0950","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12943-024-02023-w","article-title":"Regulatory mechanisms of PD-1\/PD-L1 in cancers","volume":"23","author":"Lin","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbcan.2026.189640_bb0955","first-page":"12","article-title":"An overview of nanoparticle-based delivery platforms for mRNA vaccines for treating cancer","author":"Lin","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.bbcan.2026.189640_bb0960","article-title":"Boosting cancer therapy with self-assembled inorganic nanocarriers via host-guest chemistry","volume":"37","author":"Tang","year":"2026","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.bbcan.2026.189640_bb0965","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2026.150739","article-title":"Transmembrane mechanisms and targeted delivery strategies of self-assembling peptides in tumor therapy","volume":"347","author":"Wang","year":"2026","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bbcan.2026.189640_bb0970","doi-asserted-by":"crossref","first-page":"6560","DOI":"10.7150\/thno.99931","article-title":"Supramolecularly engineered bacteria mediated calcium overload and immunotherapy of tumors","volume":"14","author":"Xie","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.bbcan.2026.189640_bb0975","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s44342-024-00034-z","article-title":"Comprehensive analysis of TCR and BCR repertoires: insights into methodologies, challenges, and applications","volume":"23","author":"Seo","year":"2025","journal-title":"Genomics Inform."},{"key":"10.1016\/j.bbcan.2026.189640_bb0980","doi-asserted-by":"crossref","first-page":"275","DOI":"10.5483\/BMBRep.2023-0024","article-title":"Immunogenic cell death in cancer immunotherapy","volume":"56","author":"Choi","year":"2023","journal-title":"BMB Rep."},{"key":"10.1016\/j.bbcan.2026.189640_bb0985","first-page":"8","article-title":"Consensus guidelines for the definition, detection and interpretation of immunogenic cell death","author":"Galluzzi","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bbcan.2026.189640_bb0990","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.tcb.2023.07.009","article-title":"Disulfidptosis: disulfide stress-induced cell death","volume":"34","author":"Liu","year":"2024","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.bbcan.2026.189640_bb0995","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3389\/fcell.2020.00167","article-title":"Cathepsin B is required for NLRP3 inflammasome activation in macrophages, through NLRP3 interaction","volume":"8","author":"Chevriaux","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bbcan.2026.189640_bb1000","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1038\/sj.bjc.6604059","article-title":"Photodynamic therapy-generated vaccines: relevance of tumour cell death expression","volume":"97","author":"Korbelik","year":"2007","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbcan.2026.189640_bb1005","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jss.2018.07.068","article-title":"Vaccination with mitoxantrone-treated primary colon cancer cells enhances tumor-infiltrating lymphocytes and clinical responses in colorectal liver metastases","volume":"233","author":"Qin","year":"2019","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.bbcan.2026.189640_bb1010","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.celrep.2016.03.037","article-title":"Vaccination with necroptotic cancer cells induces efficient anti-tumor immunity","volume":"15","author":"Aaes","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbcan.2026.189640_bb1015","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41422-025-01085-9","article-title":"Oncogenic RAS induces a distinctive form of non-canonical autophagy mediated by the P38-ULK1-PI4KB axis","volume":"35","author":"Wang","year":"2025","journal-title":"Cell Res."},{"key":"10.1016\/j.bbcan.2026.189640_bb1020","first-page":"135","article-title":"An inducible RIPK3-driven necroptotic system enhances cancer cell-based immunotherapy and ensures safety","author":"Chen","year":"2024","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2026.189640_bb1025","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcis.2025.138488","article-title":"Generation of personalized whole tumor cells vaccine for pyroptosis-enhanced anticancer immunity via Cu(2)(-)(x)Se photothermal activation under NIR irradiation","volume":"700","author":"Chang","year":"2025","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.bbcan.2026.189640_bb1030","doi-asserted-by":"crossref","first-page":"5493","DOI":"10.1158\/1078-0432.CCR-18-2992","article-title":"Results from a phase IIb, randomized, multicenter study of GVAX Pancreas and CRS-207 compared with chemotherapy in adults with previously treated metastatic pancreatic adenocarcinoma (ECLIPSE Study)","volume":"25","author":"Le","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189640_bb1035","series-title":"Randomized Phase IIB\/III Active Control Study of Second-line Tergenpumatucel-L (Hyper-Acute(R)-Lung) Immunotherapy Versus Docetaxel in Progressive or Relapsed Non-Small Cell Lung Cancer","author":"Open-label","year":"2013"},{"key":"10.1016\/j.bbcan.2026.189640_bb1040","first-page":"9","article-title":"Case report: marked survival advantage of two colorectal cancer patients with liver metastases treated with vigil and FOLFOX-6","author":"Barve","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.bbcan.2026.189640_bb1045","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/mt.2011.269","article-title":"Phase I trial of \u201cbi-shRNAi(furin)\/GMCSF DNA\/autologous tumor cell\u201dvaccine (FANG) in advanced cancer","volume":"20","author":"Senzer","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbcan.2026.189640_bb1050","doi-asserted-by":"crossref","first-page":"224","DOI":"10.2174\/1574892817666220518123331","article-title":"Regression of breast cancer metastases following treatment with irradiated SV-BR-1-GM, a GM-CSF overexpressing breast cancer cell line: intellectual property and immune markers of response","volume":"18","author":"Wiseman","year":"2022","journal-title":"Recent Pat. Anticancer Drug Discov."},{"key":"10.1016\/j.bbcan.2026.189640_bb1055","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1245\/s10434-017-6072-3","article-title":"Long-term survival after complete surgical resection and adjuvant immunotherapy for distant melanoma metastases","volume":"24","author":"Faries","year":"2017","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.bbcan.2026.189640_bb1060","first-page":"13","article-title":"Genetic variants in immune related genes as predictors of responsiveness to BCG immunotherapy in metastatic melanoma patients","author":"Ramos","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbcan.2026.189640_bb1065","article-title":"Metal-phenolic nanocloaks on cancer cells potentiate sting pathway activation for synergistic cancer immunotherapy","volume":"63","author":"He","year":"2024","journal-title":"Angew. Chem. Int. Ed. Eng."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X26001125?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X26001125?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T06:15:20Z","timestamp":1785910520000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X26001125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":213,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0304419X26001125"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2026.189640","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Programming regulated cell death to engineer whole-tumor-cell vaccines for cancer immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2026.189640","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"189640"}}